Skip to content
(614)355-5560
Central Region
June 26, 2023
Important Updates to Medication Coverage for Ohio Medicaid Patients

Partners For Kids UPDL for Ohio Medicaid Plans is now available for review on the Partners For Kids resource website.

The Ohio Department of Medicaid’s (ODM) UPDL is developed by ODM and implemented by the single Pharmacy Benefit Manager, Gainwell Technologies. Partners For Kids has condensed the UPDL into commonly prescribed drug classes for pediatric primary care and behavioral health providers.

Below is one important change that will take effect July 1, 2023. To review additional changes taking place July 1 please see our Pharmacy Coverage Updates document.

For any questions about Partners For Kids Coverage Resources, please contact PFKPharmacy@nationwidechildrens.org.

 

Related Articles
Pharmacy Updates
April 3, 2024
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
April 3, 2024
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
March 5, 2024
Updated Attention Deficit Hyperactivity Disorder (ADHD) Guidelines are Now Available – Central Region
Resources within the guideline include screening tools, treatment algorithms, and medication dosing recommendations.
Read More
Pharmacy Updates
March 5, 2024
A New Tool to Overcome Access Barriers to Spacer-Compatible Inhaled Steroids
Partners For Kids has created a pathway to guide decision-making when prescribing inhaled steroids for children.
Read More
Pharmacy Updates
March 5, 2024
A New Tool to Overcome Access Barriers to Spacer-Compatible Inhaled Steroids
Partners For Kids has created a pathway to guide decision-making when prescribing inhaled steroids for children. 
Read More
Pharmacy Updates
February 15, 2024
Updated Nicotine Dependence Prescribing Guidelines Now Available
Topics include screening and diagnostic tools, first-line behavioral modifications and external support, recommended medication and nicotine replacement therapies, and treatment time frame recommendations.
Read More